avapro has been researched along with Tachycardia, Supraventricular in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Tachycardia, Supraventricular: A generic expression for any tachycardia that originates above the BUNDLE OF HIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kataoka, N | 1 |
| Nishida, K | 1 |
| Kinoshita, K | 1 |
| Sakamoto, T | 1 |
| Nakatani, Y | 1 |
| Tsujino, Y | 1 |
| Mizumaki, K | 1 |
| Inoue, H | 1 |
| Kinugawa, K | 1 |
1 other study available for avapro and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Fibrillation; Atrial Remodeling; Biphenyl C | 2016 |